iShares Biotechnology ETF (IBB) Dividend Yield, History & Forecast

iShares Biotechnology ETF (IBB) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 0.21% ($0.41 per share annually (TTM)). The most recent ex-dividend date was June 15, 2026, with payment scheduled for June 18, 2026. market capitalization is approximately $9.21B.

IBB fund composition

IBB holds 248 positions, with 45.9% of assets in its ten largest. It charges an expense ratio of 0.44%, and manages $9.21B.

Top 10 holdings

HoldingWeight
AMGNAMGEN INC8.46%
VRTXVERTEX PHARMACEUTICALS7.81%
GILDGILEAD SCIENCES INC7.35%
REGNREGENERON PHARMACEUTICALS6.00%
ARGXARGENX SE ADR3.43%
NTRANATERA2.94%
RVMDREVOLUTION MEDICINES2.88%
ILMNILLUMINA INC2.40%
BIIBBIOGEN INC2.39%
ALNYALNYLAM PHARMACEUTICALS2.28%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about iShares Biotechnology ETF (IBB)

What is iShares Biotechnology ETF's dividend yield?
iShares Biotechnology ETF (IBB) pays a current trailing twelve-month dividend yield of 0.21%, which works out to $0.41 per share annually based on the most recent payout schedule.
When does iShares Biotechnology ETF pay distributions?
The most recent ex-dividend date was June 15, 2026. The next scheduled dividend payment date is June 18, 2026.
What does iShares Biotechnology ETF invest in?
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.